Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Pablo Mandó"'
Autor:
Federico Waisberg, Pablo Mandó, Carolina Almada, Naima Kassis, Andrea Mainella, Luciano Cermignani, María Cecilia Riggi, Melina Winocur, Ramiro González, Andres Guercovich, Natalia Ayala, Cristian Micheri, Ana Carolina Ituarte, Lucía González Mattos, Pamela Llugdar, Mónica Casalnuovo, Maribel Lutteral, Sebastián Cinquini, Alejandro Mazzotta, Janeth Lara Alcantara, Rosa Penayo, Gonzalo Gomez-Abuin
Publikováno v:
JCO Global Oncology, Vol , Iss 10 (2024)
PURPOSEThe optimal treatment sequence for hormone receptor–positive (HR+)/human epidermal growth factor receptor 2–negative (HER2–) advanced breast cancer (ABC) after progression on first-line cyclin-dependent kinase 4/6 inhibitor (CDKi) and en
Externí odkaz:
https://doaj.org/article/dd11b4d7c7f44cf28b52bc1a7d9a2c91
Publikováno v:
Breast, Vol 60, Iss , Pp 15-25 (2021)
The clinical outcome of patients with human epidermal growth factor receptor 2 (HER2) amplified breast carcinoma (BC) has improved with the development of anti-HER2 targeted therapies. However, patients can experience disease recurrence after curativ
Externí odkaz:
https://doaj.org/article/e9a4b367e156407797f9a9931fef609d
Autor:
Verónica Fabiano, Pablo Mandó, Manglio Rizzo, Carolina Ponce, Federico Coló, Martín Loza, Jose Loza, Mora Amat, Daniel Mysler, María Victoria Costanzo, Adrián Nervo, Jorge Nadal, Florencia Perazzo, Reinaldo Chacón
Publikováno v:
JCO Global Oncology, Vol , Iss 6, Pp 639-646 (2020)
PURPOSE Multiple studies have reported that breast cancer in young patients is associated with aggressive characteristics, and it is suggested that prognosis is worse independently of pathologic variables. PATIENTS AND METHODS We performed a retrospe
Externí odkaz:
https://doaj.org/article/bd68930b829f4c82925e350c5f266a10
Autor:
Pablo Mandó, Ian Hirsch, Federico Waisberg, Alexis Ostinelli, Romina Luca, Belen Pranevicene, Augusto Ferreyra Camacho, Diego Enrico, Matías Chacon
Publikováno v:
Cancer Treatment and Research Communications, Vol 27, Iss , Pp 100358- (2021)
Introduction: Breast cancer is the tumor with highest incidence in women worldwide and adjuvant treatment is extremely important to achieve disease control. Given the relevance of systematic reviews, their rigor should be warranted to avoid biased co
Externí odkaz:
https://doaj.org/article/a3d0df7027604ca6a0e8064b24c457fd
Autor:
Gonzalo H. Giornelli, Pablo Mandó
Publikováno v:
European Medical Journal, Vol 2, Iss 3, Pp 128-135 (2017)
Ovarian cancer (OC) is a disease that almost invariably relapses even after optimal primary cytoreductive surgery and standard first-line platinum-based chemotherapy. After recurrence, progressions occur at shorter intervals in the natural history of
Externí odkaz:
https://doaj.org/article/e1949d3f9e924c8198f50e501f861695
Autor:
Pablo Mandó, Federico Waisberg, Rosario Pasquinelli, Sergio Rivero, Alexis Ostinelli, Florencia Perazzo
Publikováno v:
OncoTargets and Therapy. 16:115-132
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0910a214d65936ae564e67b4f5a25362
https://doi.org/10.2147/ott.s335934
https://doi.org/10.2147/ott.s335934
Autor:
María B. Bordignon, Ayelén I. Pesce Viglietti, Estefanía P. Juliá, María B. Sanchez, Alexander Rölle, Pablo Mandó, Luciana Sabatini, Alexis Ostinelli, Manglio M. Rizzo, María M. Barrio, José Mordoh, Leonardo Fainboim, Estrella M. Levy
Publikováno v:
Cancer Immunology, Immunotherapy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a7e4bd8e9cbe19e5f180a494450a501
https://doi.org/10.1007/s00262-023-03448-w
https://doi.org/10.1007/s00262-023-03448-w
Autor:
Florencia Cascardo, Micaela Vivanco, María Cecilia Perrone, Andrea Werbach, Diego Enrico, Pablo Mando, Mora Amat, Paula Martínez-Vazquez, Javier Burruchaga, María Mac Donnell, Claudia Lanari, Ariel Zwenger, Federico Waisberg, Virginia Novaro
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract PI3K/AKT/mTOR pathway is implicated in breast cancer progression and recurrence. The identification of PIK3CA and AKT1 mutations and loss of PTEN serve as selection criterion for targeted therapies involving selective inhibitors. However, th
Externí odkaz:
https://doaj.org/article/ce09fb118a3c42c3a6eb1d50c923afd6
Autor:
Maria del Rosario Sifón, Nicolas Marcolini, Maria Julia Barber, Ignacio Mclean, Manglio Rizzo, Sergio Rivero, Maria Victoria Costanzo, Adrian Nervo, Gabriel Crimi, Florencia Perazzo, Estrella Mariel Levy, Pablo Mandó
Publikováno v:
Breast Care. 17:546-553
Background: Breast cancer is a highly heterogeneous disease with large differences in the risk of recurrence. An elevated neutrophil-to-lymphocyte ratio (NLR) is correlated with a poor prognosis in a variety of tumors, and although it is still contro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efe2be6820d9e2e98978f7a693ee8ae3
https://doi.org/10.1159/000525287
https://doi.org/10.1159/000525287
Autor:
Pablo Mandó, Rosario Vidal, Ana Alonso, Celia Brosio, Gonzalo Recondo, Gabriel Crimi, Francisco Von Stecher, Valeria Dennighoff, Florencia Perazzo
Publikováno v:
Oncología Clínica. 26
La vía PI3K es de gran importancia para diversas funciones celulares, incluyendo el metabolismo celular y la proliferación, diferenciación y supervivencia. Después de p53, esta ruta es considerada como la más afectada por alteraciones gene
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::03fd17e95f7edd112d1d07bdc65806dc
https://doi.org/10.56969/oc.v26i1.9
https://doi.org/10.56969/oc.v26i1.9